Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma

British Journal of Surgery

Volumn 97, Issue 9, 2010, Pages 1363-1368

  Konishi, M ^f   Iwasaki, M ^b   Ochiai, A ^a   Hasebe, T ^c   Ojima, H ^d   Yanagisawa, A ^e  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b Epidemiology and Prevention Division   (United States)

^c NATIONAL CANCER CENTER   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CLINICAL TRIAL; FEMALE; HEPATIC DUCT; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PEROPERATIVE CARE; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77956416139     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7122     Document Type: Article

References (26)

1. Choi SB, Park SW, Kim KS, Choi JS, Lee WJ. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol 2009; 99: 335-342.
2. Baton O, Azoulay D, Adam DV, Castaing D. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 2007; 204: 250-260.
3. Endo I, House MG, Klimstra DS, Gönen M, D'Angelica M, Dematteo RP etal. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 2 008; 15: 2104-2112.
4. Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical, management of hilar cholangiocarcinoma. Ann Surg 2005;241:693-699.
5. Jang JY, Kim SW, Park DJ, Ahn YJ, Yoon YS, Choi MG et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 2005; 241: 77-84.
6. Ojima H, Kanai Y, Iwasaki M, Hiraoka. N, Shimada K, Sano T et al. Intraductal carcinoma, component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 2009; 100: 62-70.
7. Otto G, Romaneehsen B, Hoppe-Lotichius M, Bittinger F. Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging. J Hepatobiliary Pancreat Surg 2004;11:310-318.
8. Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N et al. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg 2007; 31: 1788-1796.
9. Hernandez J, Cowgill SM, Al-Saadi S, Villadolid D, Ross S, Kraemer E et al. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection. Ann Surg Oncol 2008; 15: 807-814.
10. Okazaki Y, Horimi T, Kotaka M, Morita. S, Takasaki M. Study of the intrahepatic surgical margin of hilar bile duct carcinoma. Hepatogastroenterology 2002; 49: 625-627.
11. Albores-Saavedra J, Henson DE, Klimstra. D. Tumors of the Gallbladder, Extrahepatic Bile Duct, and Ampulla of Vater, 3rd Series. Armed Forces Institute of Pathology: Washington, DC, 2000.
12. Igami T, Nagino M, Oda. K, Nishio H, Ebata T, Yokoyama. Y et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 2009; 249: 296-302.
13. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 2005; 103: 1210-1216.
14. Konishi M, Ochiai A, Ojima H, Hasebe T, Mano M, Ohta T et al. A new histological classification for intra-operative histological examination of the ductal resection margin in cholangiocarcinoma. Cancer Sci 2008; 100: 255-260.
15. Sobin L, Wittekind C. TMN Classification of Malignant Tumors (UICC) (6th edn). John Wiley and Sons: New York, 2002.
16. Bahra. M, Jacob D, Langrehr JM, Neumann UP, Neuhaus P. Carcinoma, of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up. J Hepatobiliary Pancreat Surg 2008; 15: 501-507.
17. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Stag 2001; 234: 507-517.
18. Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15: 947-954.
19. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230: 663-671.
20. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N et al. Extended resections for hilar cholangiocarcinoma.. Ann Surg 1999; 230: 808-818.
21. Yubin L, Chihua. F, ZhixiangJ, Jinrui O, Zixian L, Jianghua. Z et al. Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China.Ann Surg Oncol 2008; 15: 2113-2119.
22. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Sarg 2003; 238: 84-92.
23. Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 2005; 137: 396-402.
24. Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol 2008; 34: 787-794.
25. Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 2004; 240: 95-101.
26. Borghero Y, Crane CH, SzklarukJ, Oyarzo M, Curley S, Pisters PW et al. Extrahepatic bile duct adenocarcinoma.: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 2008; 15: 3147-3156.